We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio (a subsidiary of Roivant ...

The LSPN Awards USA 2025, which honours standout individuals and firms making significant contributions to life sciences IP, has released its shortlist ... biotech, and medtech patent protection.

Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Stock analysts at Zacks Research reduced their Q3 2026 earnings per share estimates for shares of Gilead Sciences in a research report ...

Investing.com -- Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) climbed 7% following the company’s announcement of securing an exclusive license to a method of treatment patent for its drug candidate, ...

Investing.com -- Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) climbed 7% following the company’s announcement of securing an exclusive license to a method of treatment patent for its drug ...

AUSTIN, Texas, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ ... including an exclusive license to an issued US method of treatment patent (US 12,186,307 1) for simufilam as a ...

Cassava enters into a license agreement with Yale University granting intellectual property rights, including rights to an issued US method of treatment patent for potential ... 2025 (GLOBE NEWSWIRE) ...